Nike Co-Founder And Wife Donate $2B to Cancer Research at OHSU, Largest U.S. University Gift

Follow Drugslib on

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 18, 2025.

via HealthDay

MONDAY, Aug. 18, 2025 — Nike co-founder Phil Knight and his wife, Penny, will donate $2 billion to Oregon Health & Science University (OHSU) to expand cancer research and patient care.

The school called it the largest single donation ever made to a U.S. university.

The gift will help OHSU expand its cancer detection programs, grow access to clinical trials and simplify care for patients and families, the university said. The OHSU Knight Cancer Institute is located on the school’s Portland campus.

“We couldn’t be more excited about the transformational potential of this work for humanity,” the couple said in an OHSU news release.

This is not the first time the Knights have supported OHSU. In 2008, according to The New York Times, they donated $100 million, and in 2013 they pledged $500 million on the condition the university matched the amount within two years — a challenge OHSU successfully met.

Dr. Brian Druker, chairman of leukemia research at OHSU, said earlier donations helped launch a large-scale early cancer detection program, The Times reported.

“Penny and Phil Knight have always challenged us to do what no one else is doing,” Druker said. “It can seem impossible to navigate the health care system after being diagnosed with cancer. We’re going to change that. We have revolutionized the way we detect and treat cancer.”

Past donations have already spurred the development of blood tests to detect cancer earlier and supported breakthroughs in targeted therapies and precision medicine, Druker said.

Phil Knight, 87, built Nike into a global sportswear giant before stepping down as CEO in 2004 and retiring as chairman in 2016.

Worth an estimated $35.4 billion, according to Forbes, he is also a well-known philanthropist whose gifts have transformed athletic facilities and academic buildings at his undergraduate alma mater, the University of Oregon. Their gifts also created the university's Phil and Penny Knight Campus for Accelerating Scientific Impact.

In 2016, Knight pledged $400 million to Stanford University, where he earned his MBA, to recruit graduate students focused on solving major global issues such as poverty and climate change, The Times reported.

Large-scale gifts like this have shaped other U.S. schools, too.

In 2018, Michael Bloomberg donated $1.8 billion to Johns Hopkins University in Baltimore to support students from lower-income families. And in 2024, the widow of a Wall Street financier donated $1 billion to Albert Einstein College of Medicine in New York, making tuition free for all students, The Times reported.

Sources

  • The New York Times, Aug. 14, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-08-19 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords